Omada Health, Inc.
Omada Health, Inc. (NASDAQ: OMDA) operates a virtual care platform designed to deliver personalized, technology-enabled chronic disease management and prevention programs. The company's website is www.omadahealth.com. From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Omada Health, Inc. does
In the company’s own words
Omada Health, Inc. (NASDAQ: OMDA) operates a virtual care platform designed to deliver personalized, technology-enabled chronic disease management and prevention programs. The company's website is www.omadahealth.com.
The company's core mission centers on enabling lasting health behavior change through a human-led, technology-enabled care model called Compassionate Intelligence, which combines dedicated Care Teams with data-driven tools and artificial intelligence. Omada's platform serves employers, health insurance companies, health systems, pharmacy benefit managers, and other entities that cover program costs for their members.
Omada's primary product offerings include cardiometabolic programs addressing prediabetes, weight management, type 2 diabetes, hypertension, and high cholesterol, along with specialized support for members using GLP-1 therapies and anti-obesity medications. The company also offers Omada for MSK, a virtual physical therapy program launched in 2020 for musculoskeletal conditions. As of December 31, 2025, Omada had more than 2,000 customers and over 886,000 total members enrolled across its programs, having supported nearly two million members since inception.
The company employs 916 full-time employees and operates through a diversified go-to-market strategy spanning direct sales to employers and health systems as well as indirect distribution through health plans and pharmacy benefit managers. Omada's platform integrates connected third-party devices including scales, blood pressure monitors, and glucose monitors, receiving over 75,000 data points every 60 minutes to inform personalized care protocols.
Omada differentiates through clinical rigor, having published 30 peer-reviewed studies demonstrating clinical outcomes and economic value. The company has received recognition from the CDC's Diabetes Prevention Recognition Program, accreditations from ADCES, NCQA, and URAC, and maintains a three-year average customer retention rate exceeding 90 percent with customer satisfaction rates above 90 percent for both program implementation and ongoing customer success.
Company details
- Sector
- Healthcare
- Industry
- Health Services
- Headquarters
- SOUTH SAN FRANCISCO, CA
- Fiscal year end
- December
- CIK
- 1611115
- SIC
- 8000
Financial performance, year by year
Fiscal 2025–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Omada Health, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Omada Health, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Omada Health, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Omada Health, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Omada Health, Inc.'s last four quarterly filings that the numbers alone won't show?”